In Utero — Execution
Funds United Kingdom stillbirth-reduction initiatives with prenatal intervention and translational implementation support.
In Utero is a $50 million Wellcome Leap program directed by Sarah Stock, MD, PhD, Professor and Consultant in Maternal and Fetal Health with expertise in stillbirth and preterm birth. The program's central goal is to cut global stillbirth rates in half by creating scalable, non-invasive methods to measure, model, and predict gestational development in utero. The urgency of the problem is quantifie…
Scalable non-invasive measurement and prediction of gestational development in utero, with the goal of cutting the global stillbirth rate in half by improving early identification of at-risk pregnancies.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Proposal Template: Structure, Sections, and Writing Prompts
Use this grant proposal template to structure your summary, work plan, budget, team, impact, attachments, and reviewer evidence before adapting it to funder rules.
Write proposalGrant Writing Tips: Mistakes That Kill Deeptech Applications
Grant writing tips for deeptech founders, focused on mistakes reviewers penalize: weak fit, vague innovation, poor evidence, bad budgets, and rushed submissions.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)
🇺🇸NIH · United States
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose
NIH · United States
Funds discovering and developing a medication or device to prevent or treat substance use disorders and overdose, in two phases.
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3)
🇺🇸NIH · United States
Funds the implementation of a clinical trial in arthritis, musculoskeletal or skin disease as a phased cooperative agreement with the institute.